Natures Toolbox Raises $47.5M in Series B Funding
Nature’s Toolbox, Inc. (NTx), a Rio Rancho, NM-baseed life sciences company building next generation platforms to manufacture RNA and protein, raised $47.5M in Series B financing. The round was led by RA Capital Management and MP Peter Kolchinsky, Ph.D. joined NTx’ Board of Directors. Led by Jamie Coffin, Ph.D., CEO, NTx is developing innovative systems like NTxpress® and NTxscribe® to enable manufacturing of mRNA vaccines and protein therapeutics in an eco-friendly and sustainable way. The NTxscribe platform is a cell-free, true continuous flow manufacturing system that delivers scalable RNA materials in a small footprint. NTxpress is a fully recombinant cell-free expression system that produces proteins while minimizing unwanted cellular metabolism.